MAPK1 and Alzheimer disease: Additionally, molecular docking of the extract’s major components towards acetylcholinesterase (AChE) and extracellular regulated kinase 2 (ERK2) was performed to evaluate their potential to block these two key target enzymes in AD pathogenesis.